{"id":"https://openalex.org/W2090715569","doi":"https://doi.org/10.1128/aac.16.5.615","title":"Clinical Pharmacokinetics and Safety of High Doses of Ceforanide (BL-S786R) and Cefazolin","display_name":"Clinical Pharmacokinetics and Safety of High Doses of Ceforanide (BL-S786R) and Cefazolin","publication_year":1979,"publication_date":"1979-11-01","ids":{"openalex":"https://openalex.org/W2090715569","doi":"https://doi.org/10.1128/aac.16.5.615","mag":"2090715569","pmid":"https://pubmed.ncbi.nlm.nih.gov/526003","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/352915"},"language":"en","primary_location":{"id":"doi:10.1128/aac.16.5.615","doi":"https://doi.org/10.1128/aac.16.5.615","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.16.5.615","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/352915","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103522440","display_name":"Robert D. Smyth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert D. Smyth","raw_affiliation_strings":["Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113583782","display_name":"Morris Pfeffer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Morris Pfeffer","raw_affiliation_strings":["Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073865425","display_name":"Aaron Glick Donald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Glick Donald","raw_affiliation_strings":["Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063380006","display_name":"Rachel Harken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Van Harken","raw_affiliation_strings":["Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":null,"display_name":"Girard H. Hottendorf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Girard H. Hottendorf","raw_affiliation_strings":["Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Pharmacokinetics and Department of Clinical Research, Bristol Laboratories, Syracuse, New York 13201","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":null,"apc_paid":null,"fwci":2.5247,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.89292879,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"16","issue":"5","first_page":"615","last_page":"621"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceforanide","display_name":"ceforanide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cefazolin","display_name":"cefazolin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9549999833106995},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.718999981880188},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.7889999747276306},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7720000147819519},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.7549999952316284},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8050000071525574},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.5899999737739563},{"id":"https://openalex.org/keywords/glomerular-filtration","display_name":"glomerular filtration","score":0.6940000057220459},{"id":"https://openalex.org/keywords/tubular-secretion","display_name":"renal tubular secretion","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C2778353156","wikidata":"https://www.wikidata.org/wiki/Q415739","display_name":"Cefazolin","level":3,"score":0.9119962453842163},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8400048613548279},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7291033267974854},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5361893177032471},{"id":"https://openalex.org/C3018403923","wikidata":"https://www.wikidata.org/wiki/Q1163287","display_name":"Plasma clearance","level":3,"score":0.5225093364715576},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38130709528923035},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38107067346572876},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3785232603549957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35121479630470276},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.20593661069869995},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001798","descriptor_name":"Blood Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002435","descriptor_name":"Cefamandole","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002437","descriptor_name":"Cefazolin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002437","descriptor_name":"Cefazolin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002437","descriptor_name":"Cefazolin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.16.5.615","doi":"https://doi.org/10.1128/aac.16.5.615","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.16.5.615","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:352915","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/352915","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:526003","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/526003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:352915","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/352915","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1490477510","https://openalex.org/W1975833164","https://openalex.org/W2008424416","https://openalex.org/W2020709519","https://openalex.org/W2027607694","https://openalex.org/W2049020791","https://openalex.org/W2072007862","https://openalex.org/W2080505396","https://openalex.org/W2090388620","https://openalex.org/W2128322259","https://openalex.org/W2286608681","https://openalex.org/W2399195461","https://openalex.org/W2412832123","https://openalex.org/W2416062509","https://openalex.org/W2543084926","https://openalex.org/W2916842332","https://openalex.org/W3216143596","https://openalex.org/W4253105135","https://openalex.org/W4254039096","https://openalex.org/W4302957982","https://openalex.org/W7118072429"],"related_works":["https://openalex.org/W2088104964","https://openalex.org/W2021162273","https://openalex.org/W2025434918","https://openalex.org/W2059958957","https://openalex.org/W2084655721","https://openalex.org/W2795556488","https://openalex.org/W2233700673","https://openalex.org/W2092844011","https://openalex.org/W2065026575","https://openalex.org/W2011247731"],"abstract_inverted_index":{"The":[0,180],"pharmacokinetics":[1],"and":[2,6,20,24,42,59,72,110,171,227,248],"safety":[3],"of":[4,17,45,129,162,167,189,192,204,233,242],"ceforanide":[5],"cefazolin":[7,135],"were":[8,34,142,222],"compared":[9,125],"in":[10,36,91,134,165,182,186,236],"normal":[11],"subjects":[12],"after":[13],"30-min":[14],"intravenous":[15],"infusions":[16],"2-,":[18],"3-,":[19],"4-g":[21,25,122],"single":[22,41,123,149],"doses":[23,27,44,124],"twice-daily":[26,127],"for":[28,121,208],"10":[29],"days.":[30],"No":[31,86],"significant":[32,87],"differences":[33],"observed":[35,90,138],"plasma-renal":[37],"pharmacokinetic":[38],"parameters":[39],"between":[40],"multiple":[43,84],"ceforanide.":[46,219],"Half-life":[47],"(t((1/2)),":[48],"2.8":[49],"h),":[50,94],"plasma":[51,98,140,168,194],"clearance":[52,61,136,174,184],"(Cl(p),":[53],"48":[54],"ml/min":[55,65,103,117],"per":[56,66,104,118],"1.73":[57,67,105,119],"m(2)),":[58],"renal":[60,173,183,237],"(Cl(0-12h)":[62],"(r),":[63],"47":[64],"m(2);":[68,106],"tubular":[69,107],"secretion,":[70,108],"44%,":[71],"glomerular":[73,111,178],"filtration,":[74,112],"56%)":[75],"did":[76],"not":[77],"change":[78,88,235],"with":[79,126,199,218],"increased":[80,152,172,177],"dose":[81,150,200],"or":[82,114,246],"on":[83,240],"dosing.":[85],"was":[89,137,151,159,214,230],"t((1/2))":[92],"(1.9":[93],"area":[95,195],"under":[96,196],"the":[97,148,163,193,197],"concentration-time":[99],"curve,":[100],"Cl(r)":[101],"(60":[102],"80%,":[109],"20%),":[113],"Cl(p)":[115],"(75":[116],"m(2))":[120],"administration":[128],"cefazolin.":[130],"A":[131],"small":[132],"increase":[133,181],"when":[139,147],"concentrations":[141],"greater":[143],"than":[144],"100":[145],"mug/ml,":[146],"from":[153],"2":[154,205],"to":[155,176,206],"4":[156,207],"g;":[157],"this":[158,212],"a":[160,187,202],"result":[161],"decrease":[164],"percentage":[166],"protein":[169],"binding":[170],"due":[175],"filtration.":[179],"resulted":[185],"lack":[188],"linear":[190],"proportionality":[191],"curve":[198],"over":[201],"range":[203],"both":[209,225],"cephalosporins,":[210],"although":[211],"effect":[213],"much":[215],"less":[216],"marked":[217],"Both":[220],"compounds":[221],"well":[223],"tolerated":[224],"locally":[226],"systemically.":[228],"There":[229],"no":[231],"evidence":[232],"any":[234],"function":[238],"based":[239],"clearances":[241],"drug,":[243],"p-aminohippuric":[244],"acid,":[245],"creatinine,":[247],"other":[249],"standard":[250],"clinical":[251],"parameters.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}